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Introduction 
There are many cases of smelling disorders, which can impact an individual’s ability to smell. In 
addition, it’s important to understand there is a whole population among us who cannot smell 
(anosmia), who may have grown up never smelling (congenital anosmia), or who have reduced smell 
(hyposmia). Because the sense of smell is not as severe, life-threatening, or well-known, it is not widely 
studied. With the lack of research in this field, people with smell disorders have few treatment options. 
While there is some research on anosmia, the understanding of anosmia has plateaued, with many 
articles re-visiting known causes and common evaluation methods. More in-depth knowledge, however, 
is known only to a handful of researchers or specialized doctors. This literature review will discuss the 
research on anosmia, covering causes and effects of anosmia, with some discussion of physiology. This 
paper will also analyze relevant research that may point to potential treatments, touching on olfactory 
dysfunctions that may help us to understand anosmia. 
Basis of Smell: Pathway and Neurogenesis 
Smell is a special sense because it is processed in a different pathway than other senses. 
Olfactory information does not go through the thalamus. The neurons also do not follow “labelled lines” 
that other senses have.1 These labelled lines refer to neurons specific to each sensation. For the 
somatosensory neurons, which encode touch sensations, these labelled lines are the reason behind 
phantom limbs. When a neuron is stimulated, it tells you only pain for what it used to connect to. 
Instead of labelled lines, the olfactory system uses a “map” of multiple signals that associates each 
unique combination of signals with a unique odor. Odorants go to the olfactory epithelium, in which 
there are many olfactory receptor cells, each with a variety of receptor proteins, and with each receptor 
being specific to one chemical. When you inhale a gas mixture, all the chemical odorants activate a 
certain set of neurons, all of which simultaneously signal a specific set of glomeruli. The brain reads the 
glomeruli pattern and recognizes each unique combination as a smell.1,2 
In addition, the olfactory system is one of the few structures that can perform post-natal 
neurogenesis, or the creation of new neurons in adult life. Olfactory neurons are continuously 
regenerated from basal cells in the olfactory tract (OB), every 6 – 8 weeks.1,3,4 One study showed that 
killing new neurons resulted in a reduced cell count after 3 weeks, but a control group kept a constant 
population over time, suggesting there is an associated level of apoptosis to counterbalance the cell 
growth.  
Glia, for instance, contribute to new interneurons in the adult OB, and are essential to 
neurogenesis.4, 5 Another important aspect of neurogenesis is neuroblast migration. In rodents, the 
neurons first migrate to the subventricular zone in the brain (SVZ), then join the rostral migratory 
stream (RMS), which is a stream of cerebral spinal fluid toward the core of the OB.4,6 Chemicals in each 
glomerular layer guide migration towards the OB via chemotaxis. However, when there is injury, as one 
study simulated with lesions, new SVZ neuroblasts migrated towards the injuries rather than the RMS.4 
Studies also show neural stem cells with potential to produce neurons for the glomeruli and 
granule cells (part of olfactory pathway) exists in rodent and human OB.6 Growth factors, synaptic 
activity, rate of SVZ proliferation all regulate rate of neuronal growth and death in specific areas of the 
OB and SVZ. These neurons have dopaminergic activity and are controlled by olfactory input.6 With 
more input, there’s more renewal of olfactory neurons. The renewal of olfactory neurons in adults 
functions for odor discrimination and plasticity of the olfactory system. The plasticity peaks in early 
neuronal development, and is progressively lost as cells mature.6 
Causes of Anosmia 
Genetic 
One well known cause of anosmia is Kallmann’s Syndrome. It is an x-linked disorder which 
affects the development and migration of olfactory neurons due to abnormal hormone function.7 The 
Kallmann’s gene encodes the protein, anosmin, guides the migration of GnRH releasing neurons and 
olfactory nerves towards the hypothalamus. As a result, Kallmann’s is characterized by hypogonadism 
and anosmia. 
A lesser known and rarer genetic cause is a homozygous nonsense mutation in the SCN9A gene. 
This mutation leads to a nonfunctional voltage gated sodium channel, called Nav1.7. The result of this is 
anosmia or hyposmia associated with pain insensitivity.8,9 Patients from seven countries with this 
mutation had similar symptoms. This study suggested the Nav1.7 channel in the olfactory epithelium 
played a role in olfaction. Another study showed that this channel was expressed in the dorsal root 
ganglia of the peripheral nervous system instead.8  
 A key part of olfactory detection is having receptors to bind the chemical odorants. Genetic 
deficits resulting in the lack of olfactory receptors or non-functional odor receptors may lead to specific 
anosmia.10 Specific anosmia is a condition where the patient is anosmic towards specific odours only. 
Single nucleotide polymorphisms2 in a certain odorant receptor can lead to inability to receive signals 
towards the specific odorant that receptor should bind to. One study looked at the OR7D4 gene for 
sensitivity to androstenone. Variants of this gene led to the receptor binding to variants of 
androstenone.10 Similar studies suggests this is why odor perception may differ from person to person. 
One may say sweat is “sweet,” but another may perceive it as “pungent.”11 
Underdeveloped olfactory bulb/tract (physiology) 
It has also been suggested that the development of the olfactory centers may be the cause. 
Something commonly seen in congenitally anosmic patients is the absence or underdevelopment of the 
OB and olfactory tract.3,12,13 Because the OB is where the map of the glomeruli lies, decreasing the size 
of the bulb leads to less specific or lower resolution of odor identification, and absence of it would mean 
no perception of odors.  
The depth of the olfactory sulcus2,3,12 in the frontal cortex is also reduced for congenital 
anosmia. A depth of less than or equal to 8mm13 indicates isolated anosmia, whereas anything deeper 
does not necessarily suggest anosmia. For healthy individuals, olfactory function is correlated with the 
volume and thickness of the right frontal cortex where the olfactory sulcus lies. Olfactory function is tied 
to the left-side cortex, and a thicker piriform cortex (another structure involved in olfaction) was seen in 
congenital anosmia.12 All these structures of the brain play a role in the complex olfactory system. If 
they are reduced, it may indicate reduced olfactory function. 
Amount of neurons may lead to anosmia. Gray matter is composed of cell bodies and synapses 
and white matter are the axons. White matter is less dense than gray matter, with fewer functionally 
significant structures, like cell bodies and synapses. MRI Imaging of healthy patients revealed more gray 
matter correlated with more olfactory function. Congenitally anosmic patients had increased white 
matter, and those who acquired olfactory dysfunctions had less gray matter.12 The physiology may lead 
to anosmia, as it seems there’s less neuronal gray matter for anosmics. 
Trauma (edema/hematoma/epithelium or olfactory bulb) 
Post-traumatic olfactory loss is a common form of acquired anosmia. The mechanism behind it 
may be due to swelling or cutting off of neural pathways, or brain injury redirecting blood flow away 
from the olfactory system.14,15 One study showed that post-traumatic olfactory loss improved with 
edema or hematoma removal. Another study using fMRI imaging found that the trigeminal nerve and 
the olfactory nerve both have the same blood-dependent brain areas for their responses.14 Finally, a 
third study saw reduced cerebral blood flow to olfactory regions of the brain in patients with anosmia.16 
Together, these studies indicate that less blood flow may lead to less olfaction. 
Many reported cases reveal that spontaneous recovery occurs around 6 months to a year after 
the loss of olfaction, although it is unlikely to recover without intervention15 after this period. This 
suggests the olfactory epithelium or OB is healing and re-growing tissues and recreating neural 
connections,2,17 and  is physical damage to the epithelium or OB that reduces olfaction. 
There are also many studies that suggest damage resulting in decreased input from olfactory 
receptor cells can lead to decreased OB volume.14,15 These studies looked at olfactory loss in post-
infectious, post-traumatic, nasal polyposis and sinonasal disease patients.  
Drug-induced 
A less well known cause of anosmia is anosmia due to drugs or medical treatments. Drugs may 
act as agonists or antagonists,18 mimicking chemical signals that affect the olfactory pathway. Some 
drugs may also disturb action potentials. Cells usually use calcium influxes to release signals, but drugs 
that inhibit these calcium fluxes result in inhibited action potentials18 between cells. In the same way, 
certain drugs may alter neurotransmitter signals, inhibiting re-uptake from synaptic cleft leading to over 
stimulation.2  
There can be chemical obstructions. 2 A dry mucosa or closed taste pore18 will prevent odorants 
from diffusing over to the receptors. The drug itself may create a chemical environment18 with 
unfamiliar gradients or unbalanced concentrations of a molecule, adversely influencing signaling or the 
diffusion of signaling molecules. Infections with inflammations also cause swelling and blockage of 
odorants towards the receptors. In fact, one study showed rhinosinusitis, which presents with 
inflammation, often results in a reduced olfactory threshold.3 
Nicotine4 could also lead to olfactory disorders. Neurogenesis is vital to the maintenance of 
olfaction, as explained earlier. One study showed nicotine was detrimental the survival of new cells in 
the adult OB, and resulted in a reduced cell population, leading to reduced sense of smell. 
Age 
Age is known to be associated with hyposmia and anosmia. Data from one study shows the OB 
volume increased up to 40 years and started to decline afterwards with age.14 This may be due to the 
lower amount of available stem cells and decreased turnover rate associated with age. As stated before, 
olfactory neurons can regenerate, and their performance and plasticity peaks in early neuronal 
development, and is progressively lost as cells mature.6 As the neurons grow old, they lose their 
function. In addition to decreasing neuronal functions, another study suggested there is accelerated 
apoptosis3 contributing to turnover rate in older patients. 
Concomitant Diseases 
Many diseases and dysfunctions do present with anosmia as a side effect. Internal disorders3 
such as renal failure and diabetes may lead to anosmia. Psychiatric diseases,3 like schizophrenia and 
depression can be accompanied by anosmia as well. Neurologic diseases like Alzheimer's and 
Parkinson's are also known to have olfactory dysfunctions. Anosmia and the characteristic cognitive 
decline in patients with Alzheimer's and Parkinson's may be due to reduced blood flow to the affected 
areas, including the olfactory system.16,19 
One study looked specifically at Parkinson’s. This study suggested the cholinergic, serotonergic, 
noradrenergic systems as well as damage to the dopaminergic system are important to the  Parkinson’s 
related olfactory dysfunction.5 These systems regulate the glial activity which is involved in brain injury 
processes, and because glia is important for olfactory neurogenesis, damage to these systems could lead 
to anosmia. 
Effects of Anosmia 
Anosmia is usually known only by the symptoms, and like any disease or dysfunction, the 
symptoms are what makes research in the matter crucial and worthy of funding. This sections will 
discuss how anosmia affects patients and what anosmics experience. 
Olfactory bulb volume 
Lack of olfactory stimulation and peripheral sensory input from receptor cells leads to decreased 
volume of the OB.13,15 In a study with posttraumatic anosmia, trauma patients with damage affecting the 
pathway from olfactory receptor cells had a decrease in OB volume.  
Intranasal trigeminal nerve 
Odorants stimulate olfactory receptor neurons as well as the intranasal trigeminal nerve, which 
provides sensations in the nose like burning, itching or coolness, all of which are separate from the 
olfactory system.14,20 These are touch sensations that can contribute to the perception of an odor. 
Specifically, they are pain sensations, due to the presence of chemosensitive nociceptors and pain 
fibers. Anosmic patients were less sensitive to trigeminal sensations, meaning there was a higher 
threshold for stimulation of the nerve.20 When presented with stimuli, anosmics has smaller amplitudes 
recorded from the trigeminal nerve. However, with a longitudinal study, it was found that with time, 
trigeminal sensitivity recovered. Patients scored higher in later olfaction tests compared to testing soon 
after the loss of olfaction. Anosmic patients also have larger responses reflecting trigeminal activation in 
the respiratory epithelium. One study observed that anosmics had higher peripheral responses to CO2 
presentation, meaning their autonomic nervous system was more responsive than in healthy persons. 
Emotional/psychological 
Olfactory loss can impact the quality of life, often resulting from the loss of flavor of foods, as 
aromas are no longer present to accompany the taste. Patients with olfactory loss report bland tasting 
foods and cooking without smelling aromas, leading to weight loss and depression.3  
Also, with the absence of sense of smell, anosmic patients also need to monitor facial 
expressions from others to gauge hazards. In one study, longer term anosmia led to more accurate fear 
and disgust recognition because of their decreased ability to detect environmental hazards.21 
Smell and Taste 
Although it is commonly believed taste and smell go hand in hand, they are independent. The 
perception of taste is called flavor, which results from unique associations of three different systems. 
The gustatory system senses five basic tastes: sweet sour, salty, bitter, umani. The olfactory nerve sense 
a range of gaseous odorants, like vanilla or rotten eggs. The trigeminal nerve senses touch sensations, 
like the tingling or stinging of vapors. The combination of these contribute to the perception of taste.22 
Although loss of smell may dull flavor, it does not follow that congenital anosmics lack taste.  
Research on Olfactory Disorders and Prospective treatments 
Parosmia 
Some interesting research on parosmia, the distorted identification of odors, may shed light into 
the mechanism of olfactory receptor neuron growth. Earlier, the physiology of the olfactory system was 
discussed, going over the “map” of signals that creates what we perceive as smell. In parosmia, the 
olfactory neurons are still present, but some are lost or damaged.17 The patient can still perceive odors, 
but with certain neurons missing, the map created by a gaseous mixture is incomplete, and the “smell” 
would be skewed. Parosmia can also result from problems with the integrative centers of the central 
nervous system, where olfactory information is misinterpreted. It is suggested that following damage, 
the regenerating olfactory epithelium and OB get rewired incorrectly. 17 This means, that as the neurons 
grow back and try to reform the original synapses, they may actually connect with the wrong or 
different neurons and signal different cells leading to different “maps” created when sent to the 
glomeruli. A significant number of parosmias occur after upper respiratory tract infections (URTIs) or 
trauma, and then are followed by anosmia or hyposmia. Parosmias are more closely associated with 
hyposmia, indicating that the olfactory function is still intact at the olfactory epithelium and OB. 17  
Steroids 
Systematic and topical steroid are commonly used to treat anosmia, although there are no clear 
results. Systemically used steroid are injected or taken orally. Topically used steroid are applied like a 
lotion to a specific area.  
Systemic steroids and oral steroids have been shown to improve olfaction, but the mechanism 
behind this remains unknown.3,15 Studies showed rapid improvement if doses were administered 
constantly after surgery. However, topical steroid sprays showed no significant improvement. One study 
in Japan showed improvement with long-term administration of low-dose macrolides.3 
Another study looked at the threshold, discrimination and identification (TDI) score to measure 
improvement with steroid therapy. Topical steroids had a significant benefit in non-steroid-responsive 
anosmia, especially when budesonid was applied with neomycin.23 For steroid sensitive and non-steroid 
sensitive anosmia, initial systemic steroids also showed some improvement. 
Zinc treatment 
Oral steroid treatments like Prednisolone has had mixed results as therapy, while other drugs 
like minocycline, Vitamin A, or herbal drug combinations were not successful.24 One study focused on 
prednisolone in combination with zinc gluconate. The study administered the zinc for a month, with 
high-doses of prednisolone initially, and tapering off for 2 weeks. This resulted in improvement for 28% 
of patients. In comparison, 25% improved with just zinc, and 11% improved with only prednisolone, and 
spontaneous recovery rate with no treatment was 2%. The study also noted the OB did not change for 
those who improved. The study suggested that zinc would be helpful in treating patients with loss of 
smell, as Zinc25 seemed to be involved with regenerating olfactory neurons. Younger patients had 
stronger improvement, indicating age may be a factor in neuronal regeneration. 
Olfactory training 
One study looked at long term training, over 32 weeks. Patients exposed themselves twice daily 
to four odors for roughly 10 seconds. Olfaction did increase. However, this training was done with 
patients who lost their sense of smell under 24 months after a URTI. Previous studies have suggested 
that repeated exposure to odors can stimulate olfactory neuron growth, as well as increase the 
expression of olfactory receptors in these neurons. Even so, these studies only looked at olfactory loss 
following URTI, trauma, Parkinson’s disease, or idiopathic etiology. The success of olfactory training may 
be due to olfactory neurons3 still being present. For congenital anosmia and anosmia resulting from 
genetic deficits, the receptors or neurons are not present and cannot be created or bypassed with 
olfactory training. Also, it is important to note training improved odor discrimination, not the threshold 
for odor perception.24 
Surgical interventions 
Surgery has been used to remove drainage allowed healing of inflammations, which restored 
signal conduction pathways.3,15 It is the most common treatment for post-traumatic anosmia or URTI. 
Surgery to remove obstructions is currently the only treatment known to physicians who are not 
specialized in olfaction. 
Conclusion: Future Steps 
This review has discussed the olfactory pathway for smell perception and neurogenesis in the 
olfactory bulb. Genetic, physical, chemical causes, as well as agenesis or concomitant disease are all 
valid causes of asnomia. Anosmia leads to a decreased olfactory bulb and emotional effects, with 
remaining trigeminal and taste sensations. Research on parosmia mechanisms can shed light on how 
anosmia may develop. Finally, results from zinc treatments, steroid therapy, or olfactory training are not 
definitive, and surgery is currently the most successful for trauma and URTI patients. There is not 
enough research to show that any one treatment is significantly successful. A better understanding of 
the chemical mechanisms, signaling pathways and odor recognition is needed. Although people with 
olfactory dysfunctions such as anosmia can find a way to live with their condition, there is much interest 
in anosmia treatments amongst the anosmic community. 
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